【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Myocardial Ischemia Overview 8
Therapeutics Development 9
Pipeline Products for Myocardial Ischemia – Overview 9
Pipeline Products for Myocardial Ischemia – Comparative Analysis 10
Myocardial Ischemia – Therapeutics under Development by Companies 11
Myocardial Ischemia – Therapeutics under Investigation by Universities/Institutes 12
Myocardial Ischemia – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Myocardial Ischemia – Products under Development by Companies 16
Myocardial Ischemia – Products under Investigation by Universities/Institutes 18
Myocardial Ischemia – Companies Involved in Therapeutics Development 19
Baxter International Inc. 19
CoDa Therapeutics, Inc. 20
Lixte Biotechnology Holdings, Inc. 21
Miltenyi Biotec GmbH 22
Nyken BV 23
Opsona Therapeutics Ltd. 24
Taxus Cardium Pharmaceuticals Group Inc. 25
ViroMed Co., Ltd. 26
Myocardial Ischemia – Therapeutics Assessment 27
Assessment by Monotherapy Products 27
Assessment by Target 28
Assessment by Mechanism of Action 30
Assessment by Route of Administration 32
Assessment by Molecule Type 34
Drug Profiles 36
alferminogene tadenovec – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
AntimiR-199a – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
EP-80317 – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Gene Therapy for Ischemic Heart Failure – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Humanin – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
LB-100 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
LB-102 – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
MG-53 – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
NYK-1112 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
OPN-305 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Peptagon – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
PMC-6 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Protein for Myocardial Infarction and Critical Limb Ischemia – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Recombinant Peptide to Activate FPR2 for Ischemia Reperfusion Injury and Myocardial Ischaemia – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
Recombinant Protein to Inhibit CXCL for Cardiovascular and Immunology – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Small Molecule to Inhibit Arginase-1 and Arginase-2 for Myocardial Ischemia and Ischemia Reperfusion Injury – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Small Molecules to Activate Heat Shock Protein H11 Kinase for Myocardial Ischemia – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Small Molecules to Antagonize TRPM7 for Myocardial Ischemia and Glaucoma – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Small Molecules to Inhibit Mst1 for Myocardial Ischemia – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Stem Cell Therapy for Cardiovascular Disease – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
VM-202 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
Myocardial Ischemia – Recent Pipeline Updates 63
Myocardial Ischemia – Dormant Projects 69
Myocardial Ischemia – Product Development Milestones 70
Featured News & Press Releases 70
Jan 27, 2015: Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell & Gene Therapy Forum 70
Sep 03, 2014: Taxus Cardium to Present at the Rodman & Renshaw 16th Annual Global Investment Conference in New York City 72
Aug 13, 2014: Taxus Cardium Announces Biological and Clinical Advances in Angiogenic Gene Therapy for Heart Disease in Journal of Cardiovascular Pharmacology 73
Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention 73
Jan 27, 2014: Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings 74
May 02, 2013: Cardium Therapeutics Announces Publication Of Data On Generx In Journal Molecular Therapy 75
Nov 19, 2012: Cardium Therapeutics Announces Patent Award For Rights To Cardiovascular Gene Therapy For Treatment Of Heart Disease 76
Oct 25, 2012: Cytori Announces Japanese Approval For Clinical Studies Of Cardiovascular And Chronic Liver Disease Cell Therapy 78
May 18, 2012: New drug discovery collaborations with Queen Mary University of London launched 78
Mar 20, 2012: Cardium Therapeutics Initiates Generx Phase III Clinical Registration Study 79
Appendix 81
Methodology 81
Coverage 81
Secondary Research 81
Primary Research 81
Expert Panel Validation 81
Contact Us 81
Disclaimer 82
【レポート販売概要】
■ タイトル：心筋虚血(Myocardial Ischemia)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Myocardial Ischemia - Pipeline Review, H1 2015
■ 発行日：2015年2月24日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6276IDB
■ 調査対象地域：グローバル
- 世界の除草剤市場2014：主要企業の戦略的分析This new report from Venture Planning Group analyzes marketing strategies of the world’s leading agrochemical companies. The report contains 378 pages, 43 tables and provides agrochemical industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and R&D programs. In a highly dynam …
- 多発性硬化症：世界市場（医薬品市場予測及び分析～2022）PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update Summary Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pha …
- 歯科ポリッシングの世界市場2017-2021ABSTRACTAbout Dental Polishing Products Dental consumable products consist of small equipment and other products used in dental clinics and hospitals for the treatment of patients. It includes prophylaxis paste, dental sealants, impression materials, dental anesthetics, restorative materials, tooth whiteners, and topical fluoride. Technavio’s analysts forecast the global dental polishing products …
- ラボ用濾過の世界市場：精密濾過、限外濾過、逆浸透膜About Filtration Filtration is a method used to separate or collect a desired solid from a solution, or to remove solid impurities from a liquid. This process is done by passing a contaminated fluid through a membrane, filter paper or any other filtration media, and the pure desired filtrate is obtained on the other end. The filtration media often have a large number of pores of different sizes to …
- Scar：グローバル臨床試験レビューH2, 2013Scar Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Scar Global Clinical Trials Review, H2, 2013" provides data on the Scar clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Scar. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the …
- 世界の分路リアクトル市場2015The Global Shunt Reactor Industry Report 2015 is a professional and in-depth study on the current state of the Shunt Reactor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Shunt Reactor market analysis is provided for the international markets including development trends, competitive landscape an …
- APTT検査：米国、ヨーロッパ、日本The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and APTT testing specifically, will become more standardized, offering opport …
- 本態性血小板血症(Essential Thrombocythemia)：治療薬開発パイプライン動向（2015年上半期版）Essential Thrombocythemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H1 2015’, provides an overview of the Essential Thrombocythemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Essential Thrombocythemia, complete with comparative analysis at various stages, therapeutics asse …
- γ-オリザノールの世界市場分析：用途別（スポーツサプリメント、化粧品、医薬品、動物飼料）、セグメント予測The global gamma oryzanol market is expected to reach USD 2.06 billion by 2022, according to a new report by Grand View Research, Inc. Increasing consumer awareness towards a healthy lifestyle is expected to drive product demand over the next seven years.
- Kinder Morgan Energy Partners, L.P.：石油・ガスバリューチェーン分析レポート2013Kinder Morgan Energy Partners, L.P. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Kinder Morgan Energy Partners, L.P." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Kinder Morgan Energy Partners, L.P.”. The report provides key information relating to oil and gas assets of the company along with its opera …
- アジピン酸(ADPA)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world adipic acid market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insig …
- すず（Tin）の世界市場動向2014/2015The report presents a thorough study of tin, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing tin worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: tin production in the country, major manufacturers, tin con …
- 心臓バイオマーカー検査の世界市場：種類別（心筋マッスルクレアチンキナーゼ、トロポニン、ミオグロビン、脳性ナトリウム利尿ペプチド、虚血修飾アルブミンなど）、用途別（心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症など）、検査場所別（ポイントオブケア検査、臨床検査）The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. The prevention of cardiac diseases by monitoring heart conditions via cardiac bio …
- モバイル端末用カメラモジュールの世界市場2015-2019A camera module is integrated into devices like cameras, smartphones, tablets, laptops, automobiles, and gaming consoles and consists of a lens module, an image sensor chip, and a module case. The global market for mobile camera modules is expected to show healthy growth during the forecast period and is positively affected by factors like the rapid growth of the electronic devices market. The inc …
- 低酸素血症(Hypoxemia)：世界の治験レビュー（2015年上半期版）Hypoxemia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hypoxemia Global Clinical Trials Review, H1, 2015" provides data on the Hypoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoxemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
